Skip to main content
Mobile menu expand icon
Menu
Close
About Gimv
Investment platforms
Anchor investments
Portfolio
Team
News
Investors
en
Search
*
(Optional)
Submit
About Gimv
Investment platforms
Anchor investments
Portfolio
Team
News
Investors
Sustainability
Working at/with Gimv
Contact
Search results Search results Search results
Search results
Search
*
(Optional)
Apply
1 - 770 of 953 results
Trading update
Press release
See more info
ImCheck Awarded EUR 20.18 Million from the French Government Through the France 2030 Investment and Innovation Plan
Press release
See more info
Gimv sells stake in Mega International to Bizzdesign, establishing a strong leadership position in the Enterprise Architecture and Digital Transformation space
Press release
See more info
Biotalys Receives Approval for Large-Scale Demonstration Trials of EVOCA in the Netherlands
Press release
See more info
Max von den Hoff
Team member
See more info
Biotalys granted patents for EVOCA in both Europe and the US
Press release
See more info
ImmunOs Therapeutics AG Raises $11 Million and Further Strengthens Investor Base
Press release
See more info
Sagard acquires Groupe Acceo from Gimv
Press release
See more info
Gimv sells half of participation in Infravest to WorxInvest (communication pursuant to article 7:97 BCAC)
Press release
See more info
ImCheck Receives FDA Fast Track Designation for ICT01 in Combination with Azacitidine and Venetoclax in First-Line Acute Myeloid Leukemia for Patients Unfit for Induction Chemotherapy Treatment
Press release
See more info
Pagination
See more results